Keywords: biogen, idec/elan, receive, fda, tysabri, decision, march

Biogen Idec/Elan to receive FDA Tysabri decision by March

Article | 16 January 2006

Print This

US biotechnology major Biogen Idec and Irish drugmaker Elan says that the US Food and Drug Administration is due to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in